Science ❯ Biotechnology ❯ Drug Development

Clinical Trials

GLP-1 Receptor Agonists VG-3927 Lung Cancer RSV and Cancer Vaccines BNT327 FDA Approvals Therapeutic Innovations Mast Cell Biology Phase I Trials Safety Regulations Antisense Oligonucleotide Conjugates Regulatory Approval Long-Acting Injectables Weight Loss Mechanisms Regulatory Approvals Animal Health Phase III Trials FGF21 Analog Liver Treatments Cancer Research Biosimilar Products Biosimilar Medicines

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

The licensing deal makes Zydus the U.S. marketer and keeps Bioeq responsible for manufacturing and supply.

Tubulis Raises €308 Million Series C to Accelerate Lead Cancer ADC

Novo Nordisk to Acquire Akero for Up to $5.2 Billion to Expand in MASH

Weekly Parkinson’s Injection Secures Patent After Successful Lab Trials

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Sanofi to Acquire Vigil Neuroscience in $600M Deal to Advance Alzheimer’s Research